Recital 12, Regulation (EU) 2026/766

In forcesince 8 Apr 2026

Furthermore, Article 9(1) of Implementing Regulation (EU) 2021/620 provides that the Member States or zones thereof with disease-free status from infection with bluetongue virus (serotypes 1-24) (infection with BTV) are listed in Part I of Annex VIII to that Implementing Regulation. Commission Implementing Regulation (EU) 2026/293 [Commission Implementing Regulation (EU) 2026/293 of 9 February 2026 amending Annexes I to IV, VII, VIII, XI and XIII and correcting Annex VIII to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States, zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseases (OJ L, 2026/293, 10.2.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/293/oj).] amended the table set out in Part I of Annex VIII to Implementing Regulation (EU) 2021/620, by listing several zones in Poland as zones without disease-free status with regard to infection with BTV. However, an error has now been detected as these zones still comply with the criteria to maintain the disease-free status with regard to infection with BTV. It is therefore necessary to correct accordingly the entry for Poland in Part I of Annex VIII. Implementing Regulation (EU) 2021/620 should, therefore, be corrected accordingly.